Cindy MD - Achieve Life Chief President

ACHV Stock  USD 4.29  0.04  0.92%   

President

Cindy MD is Chief President of Achieve Life Sciences
Age 66
Address 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
Phone604-210-2217
Webhttps://www.achievelifesciences.com

Achieve Life Management Efficiency

The company has return on total asset (ROA) of (0.5409) % which means that it has lost $0.5409 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8604) %, meaning that it created substantial loss on money invested by shareholders. Achieve Life's management efficiency ratios could be used to measure how well Achieve Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Achieve Life's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 21.62 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.65). At this time, Achieve Life's Non Currrent Assets Other are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.12 in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.2 M in 2024.
Achieve Life Sciences currently holds 16.73 M in liabilities with Debt to Equity (D/E) ratio of 1.18, which is about average as compared to similar companies. Achieve Life Sciences has a current ratio of 5.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Achieve Life's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

PRESIDENT Age

Victoria BrownApellis Pharmaceuticals
44
Timothy KeutzerSpero Therapeutics
56
Meredith KayaApellis Pharmaceuticals
N/A
Kelly CarranzaAcumen Pharmaceuticals
N/A
Leslie RobbinsCytomX Therapeutics
N/A
James DohertyAcumen Pharmaceuticals
56
Phillipe BrantegemIteos Therapeutics
N/A
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. Achieve Life Sciences (ACHV) is traded on NASDAQ Exchange in USA. It is located in 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1 and employs 22 people. Achieve Life is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Achieve Life Sciences Leadership Team

Elected by the shareholders, the Achieve Life's board of directors comprises two types of representatives: Achieve Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Achieve. The board's role is to monitor Achieve Life's management team and ensure that shareholders' interests are well served. Achieve Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Achieve Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cindy MD, Chief President
Jaime Xinos, Executive Commercial
Jerry Wan, Principal Officer
Anthony Clarke, President Chief Scientific Officer, Director
Richard Stewart, Chairman of the Board, CEO
John MBA, CEO Director
Thomas MBA, Executive Chairman
Craig Donnelly, Executive CMC
Mark Rubinstein, Head Affairs

Achieve Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Achieve Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Achieve Stock Analysis

When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.